Cargando…
Schizophrenia proteomics: biomarkers on the path to laboratory medicine?
Over two million Americans are afflicted with schizophrenia, a debilitating mental health disorder with a unique symptomatic and epidemiological profile. Genomics studies have hinted towards candidate schizophrenia susceptibility chromosomal loci and genes. Modern proteomic tools, particularly mass...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1538632/ https://www.ncbi.nlm.nih.gov/pubmed/16846510 http://dx.doi.org/10.1186/1746-1596-1-11 |